Robert Hofmeister
Signal active
Chief Scientific Officer
Contact Information
Social
Primary Organization
Myeloid Therapeutics
Founded
2019
Employees
11-50
Industry
Biotechnology, Life Science, Therapeutics
Bio
Robert Hofmeister is the Chief Scientific Officer of Myeloid Therapeutics. He previously worked at Resonance Medicine, Inc. as a Chief Scientific Officer. Robert Hofmeister attended the University of Regensburg.
Location
Cambridge, Massachusetts, United States, North America
Jobs history
2
Alaunos Therapeutics
Board Member
2023 - Current
Myeloid Therapeutics
Chief Scientific Officer
2024 - Current
Educations
1
N/A
Profile Resume
Robert Hofmeister is the Chief Scientific Officer at Myeloid Therapeutics, based in United States, North America. With a background in Biotechnology, Robert Hofmeister has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.